{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:28:11Z","timestamp":1790666891502,"version":"4.1.0"},"reference-count":157,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:00:00Z","timestamp":1583539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Background: Delayed cerebral vasospasm (DCVS) due to aneurysmal subarachnoid hemorrhage (aSAH) and its sequela, delayed cerebral ischemia (DCI), are associated with poor functional outcome. Endothelin-1 (ET-1) is known to play a major role in mediating cerebral vasoconstriction. Angiotensin-II-type-1-receptor antagonists such as Sartans may have a beneficial effect after aSAH by reducing DCVS due to crosstalk with the endothelin system. In this review, we discuss the role of Sartans in the treatment of stroke and their potential impact in aSAH. Methods: We conducted a literature research of the MEDLINE PubMed database in accordance with PRISMA criteria on articles published between 1980 to 2019 reviewing: \u201cSartans AND ischemic stroke\u201d. Of 227 studies, 64 preclinical and 19 clinical trials fulfilled the eligibility criteria. Results: There was a positive effect of Sartans on ischemic stroke in both preclinical and clinical settings (attenuating ischemic brain damage, reducing cerebral inflammation and infarct size, increasing cerebral blood flow). In addition, Sartans reduced DCVS after aSAH in animal models by diminishing the effect of ET-1 mediated vasoconstriction (including cerebral inflammation and cerebral epileptogenic activity reduction, cerebral blood flow autoregulation restoration as well as pressure-dependent cerebral vasoconstriction). Conclusion: Thus, Sartans might play a key role in the treatment of patients with aSAH.<\/jats:p>","DOI":"10.3390\/brainsci10030153","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T05:37:34Z","timestamp":1583732254000},"page":"153","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Role of Sartans in the Treatment of Stroke and Subarachnoid Hemorrhage: A Narrative Review of Preclinical and Clinical Studies"],"prefix":"10.3390","volume":"10","author":[{"given":"Stefan","family":"Wanderer","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Kantonsspital Aarau, 5001 Aarau, Switzerland"},{"name":"Cerebrovascular Research Group, Neurosurgery, Department of BioMedical Research, University of Bern, 3008 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6314-2482","authenticated-orcid":false,"given":"Basil E.","family":"Gr\u00fcter","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kantonsspital Aarau, 5001 Aarau, Switzerland"},{"name":"Cerebrovascular Research Group, Neurosurgery, Department of BioMedical Research, University of Bern, 3008 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6441-4398","authenticated-orcid":false,"given":"Fabio","family":"Strange","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kantonsspital Aarau, 5001 Aarau, Switzerland"},{"name":"Cerebrovascular Research Group, Neurosurgery, Department of BioMedical Research, University of Bern, 3008 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8339-234X","authenticated-orcid":false,"given":"Sivani","family":"Sivanrupan","sequence":"additional","affiliation":[{"name":"Cerebrovascular Research Group, Neurosurgery, Department of BioMedical Research, University of Bern, 3008 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Di Santo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Neurocenter and Regenerative Neuroscience Cluster, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3378-8765","authenticated-orcid":false,"given":"Hans Rudolf","family":"Widmer","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Neurocenter and Regenerative Neuroscience Cluster, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Fandino","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kantonsspital Aarau, 5001 Aarau, Switzerland"},{"name":"Cerebrovascular Research Group, Neurosurgery, Department of BioMedical Research, University of Bern, 3008 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6305-7571","authenticated-orcid":false,"given":"Serge","family":"Marbacher","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kantonsspital Aarau, 5001 Aarau, Switzerland"},{"name":"Cerebrovascular Research Group, Neurosurgery, Department of BioMedical Research, University of Bern, 3008 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Andereggen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kantonsspital Aarau, 5001 Aarau, Switzerland"},{"name":"Cerebrovascular Research Group, Neurosurgery, Department of BioMedical Research, University of Bern, 3008 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3171\/JNS-07\/07\/0121","article-title":"Effect of delayed cerebral vasospasm on cerebrovascular endothelin A receptor expression and function","volume":"107","author":"Vatter","year":"2007","journal-title":"J. Neurosurg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0306-3623(83)90085-X","article-title":"Prostaglandin metabolism and prostacyclin in cerebral vasospasm","volume":"14","author":"Brandt","year":"1983","journal-title":"Gen. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00313153","article-title":"Prostaglandin F2 alpha levels in human cerebrospinal fluid in normal and pathological conditions","volume":"222","author":"Egg","year":"1980","journal-title":"J. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12975-013-0257-2","article-title":"Early brain injury, an evolving frontier in subarachnoid hemorrhage research","volume":"4","author":"Fujii","year":"2013","journal-title":"Transl. Stroke Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-7091-1192-5_26","article-title":"Spreading ischemia after aneurysmal subarachnoid hemorrhage","volume":"115","author":"Dreier","year":"2013","journal-title":"Acta Neurochir. Suppl."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: Proposal of a multidisciplinary research group","volume":"41","author":"Vergouwen","year":"2010","journal-title":"Stroke"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1161\/STROKEAHA.112.669788","article-title":"Impairment of cerebral autoregulation predicts delayed cerebral ischemia after subarachnoid hemorrhage: A prospective observational study","volume":"43","author":"Budohoski","year":"2012","journal-title":"Stroke"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/STROKEAHA.108.191395","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association","volume":"40","author":"Bederson","year":"2009","journal-title":"Stroke"},{"key":"ref_9","first-page":"131","article-title":"Endothelins and the cerebral circulation","volume":"7","author":"Salom","year":"1995","journal-title":"Cerebrovasc. Brain Metab. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1358\/mf.2004.26.4.831333","article-title":"Experimental approaches to evaluate endothelin-A receptor antagonists","volume":"26","author":"Vatter","year":"2004","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00006123-199810000-00083","article-title":"Endothelin and subarachnoid hemorrhage: An overview","volume":"43","author":"Zimmermann","year":"1998","journal-title":"Neurosurgery"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00701-009-0350-1","article-title":"Elevated level of endothelin-1 in cerebrospinal fluid and lack of nitric oxide in basilar arterial plasma associated with cerebral vasospasm after subarachnoid haemorrhage in rabbits","volume":"151","author":"Neuschmelting","year":"2009","journal-title":"Acta Neurochir."},{"key":"ref_13","first-page":"241","article-title":"Effect of endothelin-1 receptor antagonist BQ-123 on basilar artery diameter after subarachnoid hemorrhage (SAH) in rats","volume":"51","author":"Josko","year":"2000","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s007010070013","article-title":"Endothelin-1 initiates the development of vasospasm after subarachnoid haemorrhage through protein kinase C activation, but does not contribute to prolonged vasospasm","volume":"142","author":"Nishizawa","year":"2000","journal-title":"Acta Neurochir."},{"key":"ref_15","first-page":"1188","article-title":"Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries","volume":"52","author":"Hoel","year":"2003","journal-title":"Neurosurgery"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00234-014-1435-y","article-title":"Endothelin-1 expression and alterations of cerebral microcirculation after experimental subarachnoid hemorrhage","volume":"57","author":"Lei","year":"2015","journal-title":"Neuroradiology"},{"key":"ref_17","first-page":"237","article-title":"Cerebral angiogenesis after subarachnoid hemorrhage (SAH) and endothelin receptor blockage with BQ-123 antagonist in rats","volume":"52","author":"Josko","year":"2001","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/sj.jcbfm.9600471","article-title":"Novel mechanism of endothelin-1-induced vasospasm after subarachnoid hemorrhage","volume":"27","author":"Xie","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00701-003-0024-3","article-title":"Changes in vascular responses of the basilar artery to acetylcholine and endothelin-1 in an experimental rabbit vasospasm model","volume":"145","author":"Kim","year":"2003","journal-title":"Acta Neurochir."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/00006123-200212000-00002","article-title":"Endothelin receptor antagonists and cerebral vasospasm: An update","volume":"51","author":"Chow","year":"2002","journal-title":"Neurosurgery"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-7091-1192-5_7","article-title":"Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2)","volume":"115","author":"Macdonald","year":"2013","journal-title":"Acta Neurochir. Suppl."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e639","DOI":"10.1016\/j.wneu.2019.04.222","article-title":"Reversal of Vasospasm with Clazosentan After Aneurysmal Subarachnoid Hemorrhage: A Pilot Study","volume":"128","author":"Higashida","year":"2019","journal-title":"World Neurosurg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/15672026113109990030","article-title":"Crosstalk between the angiotensin and endothelin-system in the cerebrovasculature","volume":"10","author":"Konczalla","year":"2013","journal-title":"Curr. Neurovasc. Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., and Group, P. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med., 6.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.biopha.2018.03.164","article-title":"Cerebral ischemia induced inflammatory response and altered glutaminergic function mediated through brain AT1 and not AT2 receptor","volume":"102","author":"Justin","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1097\/HJH.0b013e32833a551a","article-title":"Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice","volume":"28","author":"Iwanami","year":"2010","journal-title":"J. Hypertens."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainres.2010.03.101","article-title":"Telmisartan suppresses cerebral injury in a murine model of transient focal ischemia","volume":"1340","author":"Kasahara","year":"2010","journal-title":"Brain Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1291\/hypres.31.161","article-title":"Attenuation of focal brain ischemia by telmisartan, an angiotensin II type 1 receptor blocker, in atherosclerotic apolipoprotein E-deficient mice","volume":"31","author":"Iwai","year":"2008","journal-title":"Hypertens. Res."},{"key":"ref_29","first-page":"585","article-title":"Telmisartan regulates the development of cerebral ischemia by alleviating endoplasmic reticulum stress","volume":"73","author":"Li","year":"2018","journal-title":"Pharmazie"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.01.025","article-title":"Effect of Telmisartan on Preventing Learning and Memory Deficits Via Peroxisome Proliferator-Activated Receptor-gamma in Vascular Dementia Spontaneously Hypertensive Rats","volume":"27","author":"Gao","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_31","first-page":"560","article-title":"Comparison of pre- and post-ischemic treatment of telmisartan and nimodipine combination in experimentally induced cerebral ischemia","volume":"54","author":"Ramanathan","year":"2016","journal-title":"Indian J. Exp. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.037","article-title":"Neurovascular protection by telmisartan via reducing neuroinflammation in stroke-resistant spontaneously hypertensive rat brain after ischemic stroke","volume":"24","author":"Kono","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/HJH.0b013e328339f1f3","article-title":"Effects of suboptimal doses of the AT1 receptor blocker, telmisartan, with the angiotensin-converting enzyme inhibitor, ramipril, on cerebral arterioles in spontaneously hypertensive rat","volume":"28","author":"Dupuis","year":"2010","journal-title":"J. Hypertens."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.06.012","article-title":"Long-term amelioration of telmisartan on metabolic syndrome-related molecules in stroke-resistant spontaneously hypertensive rat after transient middle cerebral artery occlusion","volume":"23","author":"Deguchi","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Thoene-Reineke, C., Rumschussel, K., Schmerbach, K., Krikov, M., Wengenmayer, C., Godes, M., Mueller, S., Villringer, A., Steckelings, U., and Namsolleck, P. (2011). Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023646"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1089\/neu.2009.0965","article-title":"Angiotensin II type 1 receptor blocker telmisartan reduces cerebral infarct volume and peri-infarct cytosolic phospholipase A(2) level in experimental stroke","volume":"26","author":"Kobayashi","year":"2009","journal-title":"J. Neurotrauma."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/jpet.107.120097","article-title":"Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage","volume":"322","author":"Jung","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.12.052","article-title":"Protective effect of telmisartan against progressive oxidative brain damage and synuclein phosphorylation in stroke-resistant spontaneously hypertensive rats","volume":"23","author":"Fukui","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuropharm.2006.05.029","article-title":"Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress","volume":"51","author":"Hamai","year":"2006","journal-title":"Neuropharmacology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.03.008","article-title":"Effect of combined treatment with curcumin and candesartan on ischemic brain damage in mice","volume":"20","author":"Awad","year":"2011","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s12975-015-0408-8","article-title":"Sequential Therapy with Minocycline and Candesartan Improves Long-Term Recovery After Experimental Stroke","volume":"6","author":"Soliman","year":"2015","journal-title":"Transl. Stroke Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s11064-018-2604-x","article-title":"Silencing VEGF-B Diminishes the Neuroprotective Effect of Candesartan Treatment After Experimental Focal Cerebral Ischemia","volume":"43","author":"Ishrat","year":"2018","journal-title":"Neurochem. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00210-017-1395-y","article-title":"Neuroprotective effects of AT1 receptor antagonists after experimental ischemic stroke: What is important?","volume":"390","author":"Culman","year":"2017","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Alhusban, A., Kozak, A., Pillai, B., Ahmed, H., Sayed, M.A., Johnson, M.H., Ishrat, T., Ergul, A., and Fagan, S.C. (2017). Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0178867"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s12035-015-9675-3","article-title":"Brain-Derived Neurotrophic Factor Knockdown Blocks the Angiogenic and Protective Effects of Angiotensin Modulation After Experimental Stroke","volume":"54","author":"Fouda","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1124\/jpet.113.212613","article-title":"Candesartan induces a prolonged proangiogenic effect and augments endothelium-mediated neuroprotection after oxygen and glucose deprivation: Role of vascular endothelial growth factors A and B","volume":"349","author":"Soliman","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/jpet.112.197483","article-title":"AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator","volume":"344","author":"Alhusban","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10571-014-0152-8","article-title":"Candesartan improves ischemia-induced impairment of the blood-brain barrier in vitro","volume":"35","author":"So","year":"2015","journal-title":"Cell Mol. Neurobiol."},{"key":"ref_49","first-page":"232","article-title":"Candesartan attenuates ischemic brain edema and protects the blood-brain barrier integrity from ischemia\/reperfusion injury in rats","volume":"18","author":"Panahpour","year":"2014","journal-title":"Iran. Biomed. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s12035-014-8830-6","article-title":"Low-dose candesartan enhances molecular mediators of neuroplasticity and subsequent functional recovery after ischemic stroke in rats","volume":"51","author":"Ishrat","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-3-7091-0693-8_49","article-title":"Drug repurposing for vascular protection after acute ischemic stroke","volume":"111","author":"Guan","year":"2011","journal-title":"Acta Neurochir. Suppl."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Schmerbach, K., Pfab, T., Zhao, Y., Culman, J., Mueller, S., Villringer, A., Muller, D.N., Hocher, B., Unger, T., and Thoene-Reineke, C. (2010). Effects of aliskiren on stroke in rats expressing human renin and angiotensinogen genes. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0015052"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/hr.2009.69","article-title":"Postischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats","volume":"32","author":"Yagita","year":"2009","journal-title":"Hypertens. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1124\/jpet.108.139618","article-title":"Vascular protection with candesartan after experimental acute stroke in hypertensive rats: A dose-response study","volume":"326","author":"Kozak","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/HJH.0b013e3282f2dac9","article-title":"Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF\/TrkB system in rats","volume":"26","author":"Krikov","year":"2008","journal-title":"J. Hypertens."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/01.hjh.0000209990.41304.43","article-title":"Hypertension after experimental cerebral ischemia: Candesartan provides neurovascular protection","volume":"24","author":"Fagan","year":"2006","journal-title":"J. Hypertens."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1097\/01.wnr.0000187636.13147.cd","article-title":"Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats","volume":"16","author":"Lu","year":"2005","journal-title":"Neuroreport"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"H2442","DOI":"10.1152\/ajpheart.01169.2003","article-title":"Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury","volume":"286","author":"Kusaka","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1097\/00004872-200311000-00028","article-title":"Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats","volume":"21","author":"Groth","year":"2003","journal-title":"J. Hypertens."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1161\/01.STR.31.10.2478","article-title":"Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats","volume":"31","author":"Nishimura","year":"2000","journal-title":"Stroke"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10787-010-0068-y","article-title":"Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction","volume":"19","author":"Gaur","year":"2011","journal-title":"Inflammopharmacology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neulet.2006.07.022","article-title":"Reduction of cerebral infarct size by the AT1-receptor blocker candesartan, the HMG-CoA reductase inhibitor rosuvastatin and their combination. An experimental study in rats","volume":"406","author":"Engelhorn","year":"2006","journal-title":"Neurosci. Lett."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1113\/expphysiol.2009.047936","article-title":"Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion","volume":"94","author":"Mecca","year":"2009","journal-title":"Exp. Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.brainres.2008.02.032","article-title":"Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brain","volume":"1208","author":"Schmerbach","year":"2008","journal-title":"Brain Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1161\/01.STR.0000217404.64352.d7","article-title":"AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats","volume":"37","author":"Zhou","year":"2006","journal-title":"Stroke"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1161\/STROKEAHA.108.537225","article-title":"Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke","volume":"40","author":"Kozak","year":"2009","journal-title":"Stroke"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/HJH.0b013e32830dd5ee","article-title":"Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors","volume":"26","author":"Faure","year":"2008","journal-title":"J. Hypertens."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2007.05.049","article-title":"Cooperative effect of angiotensin AT(1) and endothelin ET(A) receptor antagonism limits the brain damage after ischemic stroke in rat","volume":"570","author":"Stenman","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.STR.0000121642.53822.58","article-title":"Cerebral ischemia enhances vascular angiotensin AT1 receptor-mediated contraction in rats","volume":"35","author":"Stenman","year":"2004","journal-title":"Stroke"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.hjh.0000254376.80864.d3","article-title":"Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke","volume":"25","author":"Brdon","year":"2007","journal-title":"J. Hypertens."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00004647-200404000-00012","article-title":"The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats","volume":"24","author":"Engelhorn","year":"2004","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.WCB.0000047369.05600.03","article-title":"Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition","volume":"23","author":"Yamakawa","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ajh\/hpw099","article-title":"Transient Mild Cerebral Ischemia Significantly Deteriorated Cognitive Impairment in a Mouse Model of Alzheimer\u2019s Disease via Angiotensin AT1 Receptor","volume":"30","author":"Nakagawa","year":"2017","journal-title":"Am. J. Hypertens."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1097\/01.hjh.0000249704.34607.4c","article-title":"Synergistic protective effects of erythropoietin and olmesartan on ischemic stroke survival and post-stroke memory dysfunctions in the gerbil","volume":"24","author":"Faure","year":"2006","journal-title":"J. Hypertens."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/jnr.23532","article-title":"Different protective and reparative effects of olmesartan in stroke according to time of administration and withdrawal","volume":"93","author":"Fuentes","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1002\/jnr.22441","article-title":"An angiotensin II type 1 receptor blocker can preserve endothelial function and attenuate brain ischemic damage in spontaneously hypertensive rats","volume":"88","author":"Oyama","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neuroscience.2005.03.054","article-title":"Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia","volume":"134","author":"Hosomi","year":"2005","journal-title":"Neuroscience"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/STROKEAHA.107.503458","article-title":"Temporary pretreatment with the angiotensin II type 1 receptor blocker, valsartan, prevents ischemic brain damage through an increase in capillary density","volume":"39","author":"Li","year":"2008","journal-title":"Stroke"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.neures.2008.03.003","article-title":"Neuroprotective role of angiotensin II type 2 receptor after transient focal ischemia in mice brain","volume":"61","author":"Miyamoto","year":"2008","journal-title":"Neurosci. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/01.CIR.0000138848.58269.80","article-title":"Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation","volume":"110","author":"Iwai","year":"2004","journal-title":"Circulation"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1124\/jpet.111.182576","article-title":"Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats","volume":"339","author":"Dong","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00004647-200405000-00008","article-title":"Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat","volume":"24","author":"Lou","year":"2004","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/01.STR.30.11.2391","article-title":"Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats","volume":"30","author":"Dai","year":"1999","journal-title":"Stroke"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbrc.2011.04.142","article-title":"Irbesartan attenuates ischemic brain damage by inhibition of MCP-1\/CCR2 signaling pathway beyond AT(1) receptor blockade","volume":"409","author":"Tsukuda","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3317\/jraas.2001.009","article-title":"Non-AT(1)-receptor-mediated protective effect of angiotensin against acute ischaemic stroke in the gerbil","volume":"2","author":"Dalmay","year":"2001","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"R1526","DOI":"10.1152\/ajpregu.91040.2008","article-title":"Ischemia-induced brain damage is enhanced in human renin and angiotensinogen double-transgenic mice","volume":"297","author":"Chen","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neulet.2005.12.083","article-title":"A comparison study of cerebral protection using Ginkgo biloba extract and Losartan on stroked rats","volume":"398","author":"Loh","year":"2006","journal-title":"Neurosci. Lett."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"H1989","DOI":"10.1152\/ajpheart.00839.2004","article-title":"Angiogenic protection from focal ischemia with angiotensin II type 1 receptor blockade in the rat","volume":"288","author":"Forder","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.09.011","article-title":"Benefits of prestroke use of angiotensin type 1 receptor blockers on ischemic stroke severity","volume":"21","author":"Miyamoto","year":"2012","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1097\/HJH.0000000000000980","article-title":"Early blood pressure lowering treatment in acute stroke. Ordinal analysis of vascular events in the Scandinavian Candesartan Acute Stroke Trial (SCAST)","volume":"34","author":"Jusufovic","year":"2016","journal-title":"J. Hypertens."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/HJH.0000000000000581","article-title":"Effects of candesartan in acute stroke on activities of daily living and level of care at 6 months","volume":"33","author":"Hornslien","year":"2015","journal-title":"J. Hypertens."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/STROKEAHA.114.008512","article-title":"Effects of blood pressure-lowering treatment in different subtypes of acute ischemic stroke","volume":"46","author":"Sandset","year":"2015","journal-title":"Stroke"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(11)60104-9","article-title":"The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): A randomised, placebo-controlled, double-blind trial","volume":"377","author":"Sandset","year":"2011","journal-title":"Lancet"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1161\/01.STR.0000075777.18006.89","article-title":"The ACCESS Study: Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors","volume":"34","author":"Schrader","year":"2003","journal-title":"Stroke"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.08.006","article-title":"Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase","volume":"19","author":"Nakamura","year":"2010","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1468-1331.2007.01847.x","article-title":"Modification of neutrophil adhesion to human endothelial cell line in acute ischemic stroke by dipyridamole and candesartan","volume":"14","author":"Hallevi","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/ijs.12418","article-title":"Effects of blood pressure lowering in patients with acute ischemic stroke and carotid artery stenosis","volume":"10","author":"Jusufovic","year":"2015","journal-title":"Int. J. Stroke"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/ijs.12446","article-title":"Modest blood pressure reduction with valsartan in acute ischemic stroke: A prospective, randomized, open-label, blinded-end-point trial","volume":"10","author":"Oh","year":"2015","journal-title":"Int. J. Stroke"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00005344-200405000-00010","article-title":"Effects of valsartan and valeryl 4-hydroxy valsartan on human platelets: A possible additional mechanism for clinical benefits","volume":"43","author":"Serebruany","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1161\/STROKEAHA.113.002463","article-title":"Low glomerular filtration rate, recurrent stroke risk, and effect of renin-angiotensin system modulation","volume":"44","author":"Ovbiagele","year":"2013","journal-title":"Stroke"},{"key":"ref_101","first-page":"976","article-title":"What is better antiplatelet agent to prevent recurrent stroke?","volume":"62","author":"Wadiwala","year":"2012","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1161\/STROKEAHA.111.648576","article-title":"Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy","volume":"43","author":"Weber","year":"2012","journal-title":"Stroke"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1161\/STROKEAHA.109.555623","article-title":"Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: A PRoFESS subgroup analysis","volume":"40","author":"Bath","year":"2009","journal-title":"Stroke"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","article-title":"Telmisartan to prevent recurrent stroke and cardiovascular events","volume":"359","author":"Yusuf","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-0404.2009.01299.x","article-title":"Effect of cilnidipine vs. losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: A randomized controlled trial","volume":"121","author":"Hong","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1524-6175.2005.04254.x","article-title":"The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study","volume":"7","author":"Kjeldsen","year":"2005","journal-title":"J. Clin. Hypertens."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/00004872-200405000-00022","article-title":"The effect of losartan on global and focal cerebral perfusion and on renal function in hypertensives in mild early ischaemic stroke","volume":"22","author":"Nazir","year":"2004","journal-title":"J. Hypertens."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jstrokecerebrovasdis.2007.07.003","article-title":"Antiplatelet effect of losartan and telmisartan in patients with ischemic stroke","volume":"16","author":"Yamada","year":"2007","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s10072-018-3255-z","article-title":"Prior antiplatelet therapy is not associated with larger hematoma volume or hematoma growth in intracerebral hemorrhage","volume":"39","author":"Engel","year":"2018","journal-title":"Neurol. Sci."},{"key":"ref_110","first-page":"177","article-title":"Endothelin related pathophysiology in cerebral vasospasm: What happens to the cerebral vessels?","volume":"110","author":"Vatter","year":"2011","journal-title":"Acta Neurochir. Suppl."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-7091-1192-5_42","article-title":"Inflammation in subarachnoid hemorrhage and delayed deterioration associated with vasospasm: A review","volume":"115","author":"Provencio","year":"2013","journal-title":"Acta Neurochir. Suppl."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/156720212801619045","article-title":"Interleukin-1beta increases release of endothelin-1 and tumor necrosis factor as well as reactive oxygen species by peripheral leukocytes during experimental subarachnoid hemorrhage","volume":"9","author":"Czuba","year":"2012","journal-title":"Curr. Neurovasc. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jns.2012.12.005","article-title":"Increased circulating endothelial progenitor cells in patients with haemorrhagic and ischaemic stroke: The role of endothelin-1","volume":"325","author":"Paczkowska","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3174\/ajnr.A5024","article-title":"Feasibility and Safety of Repeat Instant Endovascular Interventions in Patients with Refractory Cerebral Vasospasms","volume":"38","author":"Andereggen","year":"2017","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.wneu.2018.07.138","article-title":"Intra-Arterial Papaverine-Hydrochloride and Transluminal Balloon Angioplasty for Neurointerventional Management of Delayed-Onset Post-Aneurysmal Subarachnoid Hemorrhage Vasospasm","volume":"119","author":"Hosmann","year":"2018","journal-title":"World Neurosurg."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12028-010-9433-3","article-title":"Preventing vasospasm improves outcome after aneurysmal subarachnoid hemorrhage: Rationale and design of CONSCIOUS-2 and CONSCIOUS-3 trials","volume":"13","author":"Macdonald","year":"2010","journal-title":"Neurocrit. Care"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3171\/jns.2005.103.6.0974","article-title":"Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage","volume":"103","author":"Raabe","year":"2005","journal-title":"J. Neurosurg."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1161\/STROKEAHA.108.519942","article-title":"Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): Randomized, double-blind, placebo-controlled phase 2 dose-finding trial","volume":"39","author":"Macdonald","year":"2008","journal-title":"Stroke"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(11)70108-9","article-title":"Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: A randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)","volume":"10","author":"Macdonald","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/STROKEAHA.111.648980","article-title":"Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling","volume":"43","author":"Macdonald","year":"2012","journal-title":"Stroke"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10143-005-0013-5","article-title":"Management of cerebral vasospasm","volume":"29","year":"2006","journal-title":"Neurosurg. Rev."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/jcbfm.2011.139","article-title":"Cerebral microvascular inflammation in DOCA salt-induced hypertension: Role of angiotensin II and mitochondrial superoxide","volume":"32","author":"Rodrigues","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1161\/HYPERTENSIONAHA.106.084939","article-title":"Cerebral hemodynamics after short- and long-term reduction in blood pressure in mild and moderate hypertension","volume":"49","author":"Zhang","year":"2007","journal-title":"Hypertension"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"161702","DOI":"10.1155\/2014\/161702","article-title":"The role of microclot formation in an acute subarachnoid hemorrhage model in the rabbit","volume":"2014","author":"Andereggen","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/ana.24147","article-title":"Losartan prevents acquired epilepsy via TGF-beta signaling suppression","volume":"75","author":"Cacheaux","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00701-017-3419-2","article-title":"Vasomodulatory effects of the angiotensin II type 1 receptor antagonist losartan on experimentally induced cerebral vasospasm after subarachnoid haemorrhage","volume":"160","author":"Wanderer","year":"2018","journal-title":"Acta Neurochir."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10143-017-0887-z","article-title":"Crosstalk between the angiotensin and endothelin system in the cerebrovasculature after experimental induced subarachnoid hemorrhage","volume":"41","author":"Wanderer","year":"2018","journal-title":"Neurosurg. Rev."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/sj.ki.5000034","article-title":"Losartan improves resistance artery lesions and prevents CTGF and TGF-beta production in mild hypertensive patients","volume":"69","author":"Granados","year":"2006","journal-title":"Kidney Int."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/STROKEAHA.113.003072","article-title":"Roles of hypertension in the rupture of intracranial aneurysms","volume":"45","author":"Tada","year":"2014","journal-title":"Stroke"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neulet.2004.10.008","article-title":"A non-enzymatic derived arachidonyl peroxide, 8-iso-prostaglandin F2 alpha, in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage participates in the pathogenesis of delayed cerebral vasospasm","volume":"373","author":"Asaeda","year":"2005","journal-title":"Neurosci. Lett."},{"key":"ref_131","first-page":"1064","article-title":"Alteration of the cerebrovascular function of endothelin B receptor after subarachnoidal hemorrhage in the rat","volume":"231","author":"Konczalla","year":"2006","journal-title":"Exp. Biol. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"H3750","DOI":"10.1152\/ajpheart.00857.2007","article-title":"Cerebrovascular ETB, 5-HT1B, and AT1 receptor upregulation correlates with reduction in regional CBF after subarachnoid hemorrhage","volume":"293","author":"Ansar","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1179\/016164102101199783","article-title":"Nonenzymatic derived lipid peroxide, 8-iso-PGF2 alpha, participates in the pathogenesis of delayed cerebral vasospasm in a canine SAH model","volume":"24","author":"Sakamoto","year":"2002","journal-title":"Neurol. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/jcbfm.2010.110","article-title":"The effects of poststroke captopril and losartan treatment on cerebral blood flow autoregulation in SHRsp with hemorrhagic stroke","volume":"31","author":"Smeda","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pbb.2014.10.005","article-title":"Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy","volume":"127","author":"Tchekalarova","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mcn.2015.02.014","article-title":"Angiotensin II and its receptor in activated microglia enhanced neuronal loss and cognitive impairment following pilocarpine-induced status epilepticus","volume":"65","author":"Sun","year":"2015","journal-title":"Mol. Cell Neurosci."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10571-015-0278-3","article-title":"Long-Term Treatment with Losartan Attenuates Seizure Activity and Neuronal Damage Without Affecting Behavioral Changes in a Model of Co-morbid Hypertension and Epilepsy","volume":"36","author":"Tchekalarova","year":"2016","journal-title":"Cell Mol. Neurobiol."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainres.2018.05.027","article-title":"The angiotensin II type I receptor antagonist losartan retards amygdala kindling-induced epileptogenesis","volume":"1694","author":"Nozaki","year":"2018","journal-title":"Brain Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"H404","DOI":"10.1152\/ajpheart.00247.2015","article-title":"Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus","volume":"310","author":"Biancardi","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1097\/00004872-199715120-00072","article-title":"Losartan reduces constrictor responses to endothelin-1 and the thromboxane A2 analogue in aortic rings from spontaneously hypertensive rats: Role of nitric oxide","volume":"15","author":"Maeso","year":"1997","journal-title":"J. Hypertens."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12975-010-0061-1","article-title":"Acute treatment with candesartan reduces early injury after permanent middle cerebral artery occlusion","volume":"2","author":"Guan","year":"2011","journal-title":"Transl. Stroke Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1291\/hypres.28.43","article-title":"Hemodynamic influences of losartan on the brain in hypertensive patients","volume":"28","author":"Oku","year":"2005","journal-title":"Hypertens. Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00221-012-3108-6","article-title":"In vivo experimental stroke and in vitro organ culture induce similar changes in vasoconstrictor receptors and intracellular calcium handling in rat cerebral arteries","volume":"219","author":"Povlsen","year":"2012","journal-title":"Exp. Brain Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3171\/jns.2006.105.3.438","article-title":"Gene expression and molecular changes in cerebral arteries following subarachnoid hemorrhage in the rat","volume":"105","author":"Vikman","year":"2006","journal-title":"J. Neurosurg."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/3-540-32967-6_8","article-title":"Angiotensin, bradykinin and the endothelium","volume":"Volume 176","author":"Dimitropoulou","year":"2006","journal-title":"Handbook of Experimental Pharmacology"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000231974","article-title":"Mechanisms underlying the vascular actions of endothelin 1, angiotensin II and bradykinin in the rat carotid","volume":"84","author":"Tirapelli","year":"2009","journal-title":"Pharmacology"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/348730a0","article-title":"Cloning and expression of a cDNA encoding an endothelin receptor","volume":"348","author":"Arai","year":"1990","journal-title":"Nature"},{"key":"ref_150","first-page":"H247","article-title":"Angiotensin-induced relaxation in isolated dog renal and cerebral arteries","volume":"240","author":"Toda","year":"1981","journal-title":"Am. J. Physiol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1172\/JCI7886","article-title":"Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation","volume":"104","author":"Tsutsumi","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/ajh\/6.6.453","article-title":"Regulation of the urinary excretion of endothelin in the rat","volume":"6","author":"Abassi","year":"1993","journal-title":"Am. J. Hypertens."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1161\/01.CIR.94.7.1752","article-title":"Postischemic antiarrhythmic effects of angiotensin-converting enzyme inhibitors. Role of suppression of endogenous endothelin secretion","volume":"94","author":"Brunner","year":"1996","journal-title":"Circulation"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0167-4889(93)90010-M","article-title":"Regulation of endothelin-1 mRNA by angiotensin II in rat heart endothelial cells","volume":"1178","author":"Chua","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/01.HYP.19.2.131","article-title":"Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries","volume":"19","author":"Dohi","year":"1992","journal-title":"Hypertension"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ki.1992.361","article-title":"Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells","volume":"42","author":"Kohno","year":"1992","journal-title":"Kidney Int."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10571-006-9009-0","article-title":"Mechanisms of the Anti-Ischemic Effect of Angiotensin II AT(1) Receptor Antagonists in the Brain","volume":"26","author":"Saavedra","year":"2006","journal-title":"Cell Mol. Neurobiol."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/10\/3\/153\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:05:07Z","timestamp":1760173507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/10\/3\/153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,7]]},"references-count":157,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["brainsci10030153"],"URL":"https:\/\/doi.org\/10.3390\/brainsci10030153","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,7]]}}}